V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Steris Executive Compensation (FY26)

STE · Executive and director compensation, fiscal 2024 to 2026
Data as of September 7, 2026Latest filing (8-K): August 6, 2026
324 figures on this page: 315 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
Daniel Carestio, President and Chief Executive Officer, received $11,508,522 in total compensation for fiscal 2026, and Carestio's total was 7.8% higher than the $10,673,062 reported for fiscal 2025. The company reported a chief executive pay ratio of 157:1 for fiscal 2026, against median employee compensation of $73,280. Shareholders supported the say-on-pay proposal with 90.1% of votes cast for or against in favor at the meeting held July 31, 2026 for fiscal 2026. Companies named in the disclosed peer group include Agilent Technologies, Inc., Baxter International Inc., Bio-Rad Laboratories, Inc., Boston Scientific Corporation and Dentsply Sirona Inc., among others.
Chief executive, fiscal 2026
◇
Daniel Carestio
Median of the other named officers
$2,450,424
5 officers, excluding the chief executive
Latest say-on-pay support
=
July 31, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2025 to fiscal 2026
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Daniel Carestio: $10,673,062 → $11,508,522 (7.8% higher)
CEO pay ratio: 151:1 → 157:1 (4.0% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Steris' chief executive and what were they paid?
Daniel Carestio, President and Chief Executive Officer, received $11,508,522 in total compensation for fiscal 2026. Carestio's total was 7.8% higher than the $10,673,062 reported for fiscal 2025.
What was Steris' say-on-pay result?
Shareholders supported the say-on-pay proposal with 90.1% of votes cast for or against in favor at the meeting held July 31, 2026 for fiscal 2026.
Which companies are in Steris' peer group?
Companies named in the disclosed peer group include Agilent Technologies, Inc., Baxter International Inc., Bio-Rad Laboratories, Inc., Boston Scientific Corporation and Dentsply Sirona Inc., among others.
What is Steris' chief executive pay ratio?
The company reported a chief executive pay ratio of 157:1 for fiscal 2026, against median employee compensation of $73,280.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Carestio
President and Chief Executive Officer
◇—◇◇◇—◇◇
Michael Tokich
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
J. Adam Zangerle
Senior Vice President, General Counsel and Company Secretary
◇—◇◇◇—◇◇
Cary Majors
Senior Vice President and President, Healthcare
◇—◇◇◇—◇◇
Mary Clare Fraser
Senior Vice President and Chief Human Resources Officer
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Carestio
President and Chief Executive Officer
◇—◇◇◇—◇◇
Michael Tokich
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
J. Adam Zangerle
Senior Vice President, General Counsel and Company Secretary
◇—◇◇◇—◇◇
Cary Majors
Senior Vice President and President, Healthcare
◇—◇◇◇—◇◇
Mary Clare Fraser
Senior Vice President and Chief Human Resources Officer
◇—◇◇◇—◇◇
Fiscal 2026
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Daniel Carestio
President and Chief Executive Officer
◇—◇◇◇—◇◇
Karen Burton
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
J. Adam Zangerle
Senior Vice President, General Counsel and Company Secretary
◇—◇◇◇—◇◇
Cary Majors
Senior Vice President and President, Healthcare
◇—◇◇◇—◇◇
Michael Tokich
Senior Financial Advisor (Former Senior Vice President and Chief Financial Officer)
Departed during or after this year
◇—◇◇◇—◇◇
Mary Clare Fraser
Senior Vice President and Chief Human Resources Officer
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2026
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Cary L. MajorsOPTION◇——◇—◇◇
Cary L. MajorsRSU◇——◇——◇
Daniel A. CarestioRSU◇——◇——◇
Daniel A. CarestioOPTION◇——◇—◇◇
J. Adam ZangerleOPTION◇——◇—◇◇
J. Adam ZangerleRSU◇——◇——◇
Karen L. BurtonOPTION◇——◇—◇◇
Karen L. BurtonRSU◇——◇——◇
Karen L. BurtonOTHER◇—————◇
Karen L. BurtonOPTION◇——◇—◇◇
Mary Clare FraserOPTION◇——◇—◇◇
Mary Clare FraserRSU◇——◇——◇
Michael J. TokichOPTION◇——◇—◇◇
Michael J. TokichRSU◇——◇——◇
Fiscal 2025 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2026 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Karen BurtonOption◇—◇6/04/2034
Option◇—◇5/31/2033
RSU◇◇——
RSU◇◇——
Option◇—◇6/03/2035
RSU◇◇——
RSU◇◇——
Option◇—◇10/01/2035
Option◇—◇6/02/2032
RSU◇◇——
Daniel CarestioOption◇—◇6/04/2034
Option◇—◇6/02/2032
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇5/31/2033
RSU◇◇——
Option◇—◇6/03/2035
Mary Clare FraserRSU◇◇——
Option◇—◇6/03/2035
Option◇—◇5/31/2033
RSU◇◇——
RSU◇◇——
Option◇—◇6/02/2032
RSU◇◇——
Option◇—◇6/04/2034
Michael TokichRSU◇◇——
Option◇—◇6/04/2034
RSU◇◇——
Option◇—◇6/03/2035
RSU◇◇——
Option◇—◇5/31/2033
RSU◇◇——
Option◇—◇6/02/2032
J. Adam ZangerleOption◇—◇6/03/2035
RSU◇◇——
Option◇—◇5/31/2033
Option◇—◇6/02/2032
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇6/04/2034
Cary MajorsRSU◇◇——
RSU◇◇——
Option◇—◇6/02/2032
RSU◇◇——
Option◇—◇6/03/2035
Option◇—◇5/31/2033
RSU◇◇——
Option◇—◇6/04/2034
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2026
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Dr. Mohsen M. Sohi
Board chair
◇◇◇———◇
Richard C. Breeden
◇◇◇———◇
Christopher S. Holland
◇◇————◇
Cynthia L. Feldmann
◇◇◇———◇
Dr. Esther M. Alegria
◇◇◇———◇
Paul E. Martin
◇◇◇———◇
Louis A. Shapiro
◇◇————◇
Dr. Nirav R. Shah
◇◇◇———◇
Pierre Boulud
—◇————◇
Dr. Jacqueline B. Kosecoff, Daniel A. Carestio and Dr. Richard M. Steeves served on the board in fiscal 2026 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as Stock Options and CRSUs (split evenly).

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2026
  • Agilent Technologies, Inc. A
  • Baxter International Inc. BAX
  • Bio-Rad Laboratories, Inc. BIO
  • Boston Scientific Corporation BSX
  • Dentsply Sirona Inc. XRAY
  • Edwards Lifesciences Corp. EW
  • GE Healthcare Technologies Inc. GEHC
  • Hologic, Inc. HOLX
  • IDEXX Laboratories, Inc. IDXX
  • Mettler Toledo International Inc. MTD
  • ResMed, Inc. RMD
  • Revvity, Inc. RVTY
  • Teleflex Incorporated TFX
  • The Cooper Companies, Inc. COO
  • Waters Corporation WAT
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2026July 31, 2026=◇◇◇
2025July 31, 2025=◇◇◇
2024August 1, 2024=◇◇◇
2023August 1, 2024=◇◇◇
2022July 27, 2023=◇◇◇
2021July 28, 2022=◇◇◇
2020July 29, 2021=◇◇◇
2019July 28, 2020=◇◇◇
2018July 30, 2019=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Steris files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Steris disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Steris sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Steris' disclosed peer group is defensible, who names Steris back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
324 figures on this page: 315 cited to the filing that reported them, 9 calculated from figures it prints.
315 cited to the filing
9 calculated from the filing

Documents cited

  1. 0001193125-26-338137
  2. 0001193125-26-267599
    2023 Summary Compensation Table · CEO to Median Employee Pay Ratio · Director Compensation Table for Fiscal 2026 · FISCAL 2026 SUMMARY COMPENSATION TABLE · and 3 more sections
  3. 0001757898-25-000007
  4. 0001193125-25-139947
    FISCAL 2025 SUMMARY COMPENSATION TABLE
  5. 0001193125-24-191556
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001193125-24-159955
    FISCAL 2024 SUMMARY COMPENSATION TABLE
  7. 0001193125-23-196145
  8. 0001193125-22-206687
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001193125-21-233329
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001757898-20-000018
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001193125-19-208749
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Steris executive compensation, FY2024–FY2026.” https://intel.velarion.ai/comp/STE (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Steris and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Steris discloses

The companies named in STE's own disclosed peer group.

Agilent Technologies, Inc.Baxter International Inc.Bio-Rad Laboratories, Inc.Boston Scientific CorporationDentsply Sirona Inc.Edwards Lifesciences Corp.GE Healthcare Technologies Inc.Hologic, Inc.Mettler Toledo International Inc.ResMed, Inc.Revvity, Inc.Teleflex IncorporatedThe Cooper Companies, Inc.Waters CorporationZimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy